Candlelites

Everything from Everywhere

balderton joins $30m series d for big data biotech platform play, sophia genetics

balderton joins $30m series d for big data biotech platform play, sophia genetics News Article With The full text news. The Resource Link is down the post and you can View this News Article in the source page.



balderton joins $30m series d for big data biotech platform play, sophia genetics

switzerland based saas startup sophia genetics is hoping to give ibm watson a run for its money in the healthcare diagnostics space. it’s built a big data analytics platform that harnesses clinicians’ medical expertise to enhance genomic diagnostic via ai algorithms — leading, it says, to better and faster diagnoses for patients with diseases such as cancer.hospitals that use the platform are intended to jointly benefit from expert-fed, algorithmic dna sequencing diagnostic insights exactly because they are shared across the platform. so as the user-base scales — it says it’s adding 10 new hospitals each month — sophia genetics’ ais get smarter and more accurate, and patients anywhere can benefit from the pooled knowledge.the company is announcing a $30 million series d funding round today, adding uk-based vc firm balderton capital to its investor roster, along with 360 capital partners. previous investors including uk tech entrepreneur mike lynch’s invoke capital, and alychlo, started by mark coucke, a belgian pharmaceutical entrepreneur.according to crunchbase the biotech business has raised $28.75m since being founded back in 2011, so has pulled in in the region of $58.75m thus far — capital that’s been used to develop its platform proposition to a tipping point of utility, as co-founder and ceo dr jurgi camblong explains.as the cost of genome sequencing has come down he says the challenge for healthcare providers has been quickly and accurately read...